These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15571844)

  • 1. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Shelton R
    Eur Heart J; 2004 Dec; 25(23):2174; author reply 2174-5. PubMed ID: 15571844
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrical cardioversion for AF-the state of the art.
    Gall NP; Murgatroyd FD
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):554-67. PubMed ID: 17437583
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of angiotensin-converting enzyme inhibitors in the maintenance of sinus rythm after conversion of arterial fibrillation].
    Grecu M; Olteanu RO; Olteanu SS; Georgescu CA
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):607-12. PubMed ID: 18293688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The therapeutic efficiency of complex-ACE inhibitor (perindopril) and traditional antiarrhythmic-treatment for prevention atrial fibrillation paroxysms after successful electric cardio version].
    Abuladze GV; Dzhindzholiia NR; Narsiia EV; Dzhincharadze BZ; Kadzhaia TZ
    Georgian Med News; 2008 Feb; (155):17-9. PubMed ID: 18401049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is cardioversion always needed in atrial fibrillation?].
    Toivonen L
    Duodecim; 2003; 119(3):171-2. PubMed ID: 12650014
    [No Abstract]   [Full Text] [Related]  

  • 6. [PAFAC Study. Secondary prevention of atrial fibrillation after cardioversion].
    Nitschmann S; Antz M; Kuck KH
    Internist (Berl); 2005 Jul; 46(7):800-2. PubMed ID: 15947902
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial fibrillation: new theories, emerging treatments.
    Johnson J; Napier KT
    JAAPA; 2005 Jun; 18(6):36-41; quiz 43-4. PubMed ID: 15977854
    [No Abstract]   [Full Text] [Related]  

  • 8. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
    Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic aims for atrial fibrillation in patients with heart failure].
    Lewalter T; Nitschmann S
    Internist (Berl); 2009 Jan; 50(1):101-3. PubMed ID: 19137270
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
    Kalus JS; Coleman CI; White CM
    J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacological prevention of atrial fibrillation after cardioversion].
    López Gil M; Arribas F; Cosío FG
    Rev Esp Cardiol; 1994 Nov; 47(11):715-8. PubMed ID: 7800899
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials, the renin angiotensin system and atrial fibrillation.
    Birnie DH; Gollob M; Healey JS
    Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Med Clin North Am; 2008 Jan; 92(1):101-20, xi. PubMed ID: 18061000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Restoration of the sinus rhythm in atrial fibrillation].
    Talajic M; MacDonald R; Nattel S
    Can J Cardiol; 1996 Feb; 12 Suppl A():27A-34A. PubMed ID: 8673949
    [No Abstract]   [Full Text] [Related]  

  • 16. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic atrial fibrillation in adults: direct current cardioversion or medical cardioversion].
    Fradi I; Mokaddem A; Selmi K; Boujnah MR
    Tunis Med; 2006 Dec; 84(12):772-6. PubMed ID: 17288278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis.
    Gorenek B; Cavusoglu Y; Goktekin O; Birdane A; Kudaiberdieva G; Ata N; Unalir A; Timuralp B
    Int J Cardiol; 2006 Jan; 106(2):268-9. PubMed ID: 16321704
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of angiotensin-converting enzyme inhibitors in the prevention of atrial fibrillation.
    Finkielstein D; Schweitzer P
    Am J Cardiol; 2004 Mar; 93(6):734-6. PubMed ID: 15019879
    [No Abstract]   [Full Text] [Related]  

  • 20. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B; Straumann E; Bertel O
    Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.